Skip to main content

UBS Group AG

Position in GALT — Galectin Therapeutics Inc

CIK 1610520 ZURICH, V8

Position in GALT

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$501,475
+$338,804 QoQ
Shares Held
179,741
+359.6% QoQ
Ownership
0.273%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. GALT ranks #288 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GALT

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $501,475 179,741
2025-12-31 $162,671 39,104
2025-09-30 $133,617 31,514
2025-06-30 $354,193 167,865
2025-03-31 $63,736 52,244
2024-12-31 $66,795 51,780
2024-09-30 $39,413 14,332
2024-06-30 $29,847 13,207
2023-12-31 $1,032 622
2022-12-31 $6,283 5,561
2022-06-30 $2,326 1,776
2021-09-30 $7,713 1,988
2021-06-30 $3,200 1,000
2021-03-31 $14,005 6,454
2020-12-31 $52,792 23,568
2020-09-30 $7,999 2,996
2020-06-30 $37,947 12,401
2020-03-31 $49,017 25,009